NeuroDerm Parkinson’s Drug Inches Closer To Market With Phase III Win

 
• By Alaric DeArment
  
Mitsubishi Tanabe Pharma subsidiary NeuroDerm announced positive Phase III results from its Parkinson's drug trial • Source: Shutterstock

More from Clinical Trials

More from R&D